Cargando…
Improved immunologic response to COVID‐19 vaccine with prolonged dosing interval in haemodialysis patients
Vaccination against 2019 coronavirus disease (COVID‐19) can reduce disease incidence and severity. Dialysis patients demonstrate a delayed immunologic response to vaccines. We determined factors affecting the immunologic response to COVID‐19 vaccines in haemodialysis patients. All patients within a...
Autores principales: | Haarhaus, Mathias, Duhanes, Monica, Leševic, Nataša, Matei, Bogdan, Ramsauer, Bernd, Da Silva Rodrigues, Rui, Su, Jun, Haase, Michael, Santos‐ Araújo, Carla, Macario, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115353/ https://www.ncbi.nlm.nih.gov/pubmed/35244289 http://dx.doi.org/10.1111/sji.13152 |
Ejemplares similares
-
Immunogenicity of a first dose of mRNA- or vector-based SARS-CoV-2 vaccination in dialysis patients: a multicenter prospective observational pilot study
por: Lesny, Paul, et al.
Publicado: (2021) -
Risk prediction of COVID-19 incidence and mortality in a large multi-national hemodialysis cohort: implications for management of the pandemic in outpatient hemodialysis settings
por: Haarhaus, Mathias, et al.
Publicado: (2021) -
Humoral immunogenicity and tolerability of heterologous ChAd/BNT compared with homologous BNT/BNT and ChAd/ChAd SARS-CoV-2 vaccination in hemodialysis patients: A multicenter prospective observational study
por: Haase, Michael, et al.
Publicado: (2022) -
QT interval in CKD and haemodialysis patients
por: Di Iorio, Biagio, et al.
Publicado: (2013) -
Urea Concentration and Haemodialysis Dose
por: Vartia, Aarne
Publicado: (2012)